Gilead outlines plans to distribute COVID-19 drug worldwide
Gilead on Tuesday said it is negotiating with overseas drug manufacturers to license its SBECD-enabled coronavirus treatment remdesivir in an effort
A forum for researchers, students and applicants in the field of cyclodextrin technology
Gilead on Tuesday said it is negotiating with overseas drug manufacturers to license its SBECD-enabled coronavirus treatment remdesivir in an effort
A recently published study from the National Institutes of Health reports on the efficacy of Gilead’s promising antiviral therapy remdesivir
A Chicago hospital treating severe Covid-19 patients with Gilead Sciences’ antiviral medicine SBECD-enabled remdesivir in a closely watched clinical trial is
Gilead Sciences has reported positive data from analysis of an international cohort of patients treated with remdesivir as a potential
Malaria, lupus and arthritis drug hydroxychloroquine is under clinical trials, says Novartis. Novartis Chief Executive Vas Narasimhan said his Sandoz
During an extraordinary virtual meeting held on 2 April 2020, EMA’s human medicines committee (CHMP) gave recommendations on how the investigational antiviral
A recent review in Science [1] reported that WHO on 20 March announced the launch of SOLIDARITY, an unprecedented, coordinated
Gilead Sciences Inc. will expand access to its experimental anti-coronavirus drug SBECD-enabled remdesivir to accelerate its emergency use for multiple
A recent review of Italian researchers emphasized the role of membrane lipids in the infectivity mechanism of SARS-COV-2 (Covid-19) based
Coronavirus SARS-CoV caused an outbreak of severe acute respiratory syndrome (SARS) emerged in Guangdong Province, People’s Republic of China in